Literature DB >> 6412426

Action of EDTA-Tris and antimicrobial agent combinations on selected pathogenic bacteria.

R E Wooley, M S Jones.   

Abstract

The concentration of EDTA-Tris (3.22 mM EDTA and 0.05 M Tris) used as a lavage to treat otitis externa, cystitis or other persistent infections in dogs and cats, was found to prevent the growth of Pseudomonas aeruginosa, Staphylococcus aureus and beta streptococci when present in growth media. Pseudomonas aeruginosa was rapidly lysed in this solution. Escherichia coli and Proteus vulgaris grew in the presence of EDTA-Tris, but to a lesser extent than the controls without these compounds. Minimal inhibitory concentrations (MIC) for 8 antimicrobial agents with and without EDTA-Tris were determined for E. coli and P. vulgaris. A potentiation effect on E. coli (greater than 50% decrease MIC) was observed when EDTA-Tris was combined with penicillin, oxytetracycline or chloramphenicol. A similar effect was observed with P. vulgaris when combinations of EDTA-Tris plus gentamicin, oxytetracycline, polymyxin-B or triple sulfa were used. The results of this study indicate that EDTA-Tris appears to have merit in selected cases of otitis externa, cystitis or other persistent infections where lavage might be used.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6412426     DOI: 10.1016/0378-1135(83)90079-2

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Microfluidic concentration of bacteria by on-chip electrophoresis.

Authors:  Dietmar Puchberger-Enengl; Susann Podszun; Helene Heinz; Carsten Hermann; Paul Vulto; Gerald A Urban
Journal:  Biomicrofluidics       Date:  2011-12-02       Impact factor: 2.800

Review 2.  EDTA: An Antimicrobial and Antibiofilm Agent for Use in Wound Care.

Authors:  Simon Finnegan; Steven L Percival
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-07-01       Impact factor: 4.730

3.  Antimicrobial effect of combinations of EDTA-Tris and amikacin or neomycin on the microorganisms associated with otitis externa in dogs.

Authors:  T A Sparks; D T Kemp; R E Wooley; P S Gibbs
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

4.  Screening of compound library identifies novel inhibitors against the MurA enzyme of Escherichia coli.

Authors:  Diksha Raina; Harshita Tiwari; Smriti Sharma; Praveen Kumar Chinthakindi; Amit Nargotra; Payare L Sangwan; Kandasamy Eniyan; Urmi Bajpai; Ram A Vishwakarma; Farrah Gul Khan; Saurabh Saran; Inshad Ali Khan
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-16       Impact factor: 4.813

5.  Incorporation of proteinase inhibitors into silk-based delivery devices for enhanced control of degradation and drug release.

Authors:  Eleanor M Pritchard; Thomas Valentin; Detlev Boison; David L Kaplan
Journal:  Biomaterials       Date:  2010-10-14       Impact factor: 12.479

6.  In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa.

Authors:  Zhenqiu Liu; Yaying Lin; Qi Lu; Fang Li; Jialin Yu; Zhengli Wang; Yu He; Chao Song
Journal:  Infection       Date:  2016-05-17       Impact factor: 3.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.